EMEA-000402-PIP03-17-M02

  • Email
  • Help

Overview

Product details for Vimpat
Invented nameVimpat
Active substance

Lacosamide

Decision numberP/0048/2018
PIP numberEMEA-000402-PIP03-17-M02
Pharmaceutical form(s)Film-coated tablet; Syrup; Solution for infusion
Condition(s)/indication(s)

Treatment of generalised epilepsy and epileptic syndromes

Route(s) of administrationOral use; Intravenous use
PIP applicant

UCB Pharma S.A.
Tel. +32 25599454
E-mail: albano.attrice@ucb.com

Decision typePM: decision on the application for modification of an agreed PIP

Decision